These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18508079)

  • 21. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
    Brown WL; Mastico RA; Wu M; Heal KG; Adams CJ; Murray JB; Simpson JC; Lord JM; Taylor-Robinson AW; Stockley PG
    Intervirology; 2002; 45(4-6):371-80. PubMed ID: 12602361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral genomic single-stranded RNA directs the pathway toward a T=3 capsid.
    Basnak G; Morton VL; Rolfsson O; Stonehouse NJ; Ashcroft AE; Stockley PG
    J Mol Biol; 2010 Feb; 395(5):924-36. PubMed ID: 19913556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic allostery controls coat protein conformer switching during MS2 phage assembly.
    Dykeman EC; Stockley PG; Twarock R
    J Mol Biol; 2010 Feb; 395(5):916-23. PubMed ID: 19913554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide display on live MS2 phage: restrictions at the RNA genome level.
    van Meerten D; Olsthoorn RCL; van Duin J; Verhaert RMD
    J Gen Virol; 2001 Jul; 82(Pt 7):1797-1805. PubMed ID: 11413393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and stability of icosahedral particles of a covalent coat protein dimer of bacteriophage MS2.
    Plevka P; Tars K; Liljas L
    Protein Sci; 2009 Aug; 18(8):1653-61. PubMed ID: 19521994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel delivery platform based on Bacteriophage MS2 virus-like particles.
    Fu Y; Li J
    Virus Res; 2016 Jan; 211():9-16. PubMed ID: 26415756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells.
    Naskalska A; Heddle JG
    Nanomedicine (Lond); 2024; 19(12):1103-1115. PubMed ID: 38629576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Landscape of the PP7 Virus-like Particle for Peptide Display.
    Keshavarz-Joud P; Zhao L; Bobe D; Hernandez C; Kopylov M; Yen LY; Djeddar N; Thompson B; Connors C; Gibson G; Bryksin A; Finn MG
    ACS Nano; 2023 Sep; 17(18):18470-18480. PubMed ID: 37669408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MS2 coat protein shell is likely assembled under tension: a novel role for the MS2 bacteriophage A protein as revealed by small-angle neutron scattering.
    Kuzmanovic DA; Elashvili I; Wick C; O'Connell C; Krueger S
    J Mol Biol; 2006 Feb; 355(5):1095-111. PubMed ID: 16359706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.
    Caldeira J; Bustos J; Peabody J; Chackerian B; Peabody DS
    PLoS One; 2015; 10(10):e0141407. PubMed ID: 26516771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-plasmid double-expression His-tag system for rapid production and easy purification of MS2 phage-like particles.
    Mikel P; Vasickova P; Kralik P
    Sci Rep; 2017 Dec; 7(1):17501. PubMed ID: 29235545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
    Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
    Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Selection for Assembly Reveals That a Single Amino Acid Mutant of the Bacteriophage MS2 Coat Protein Forms a Smaller Virus-like Particle.
    Asensio MA; Morella NM; Jakobson CM; Hartman EC; Glasgow JE; Sankaran B; Zwart PH; Tullman-Ercek D
    Nano Lett; 2016 Sep; 16(9):5944-50. PubMed ID: 27549001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data.
    Liekniņa I; Kalniņš G; Akopjana I; Bogans J; Šišovs M; Jansons J; Rūmnieks J; Tārs K
    J Nanobiotechnology; 2019 May; 17(1):61. PubMed ID: 31084612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactive epitope mimics in a fragmented-genome phage display library derived from the rickettsia, Cowdria ruminantium.
    Fehrsen J; du Plessis DH
    Immunotechnology; 1999 Mar; 4(3-4):175-84. PubMed ID: 10231087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal packing of a bacteriophage MS2 coat protein mutant corresponds to octahedral particles.
    Plevka P; Tars K; Liljas L
    Protein Sci; 2008 Oct; 17(10):1731-9. PubMed ID: 18662904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae.
    Sun S; Li W; Sun Y; Pan Y; Li J
    Biochem Biophys Res Commun; 2011 Apr; 407(1):124-8. PubMed ID: 21362402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.